TY - JOUR
T1 - Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor α
AU - Viganò, Alessandra
AU - Bricalli, Dorella
AU - Trabattoni, Daria
AU - Salvaggio, Antonino
AU - Ruzzante, Stefania
AU - Barbi, Maria
AU - Sanzo, Giuseppe D I
AU - Principi, Nicola
AU - Clerici, Mario
PY - 1998/6/10
Y1 - 1998/6/10
N2 - Vaccination of HIV-infected individuals increases HIV viral load, reduces CD4 cell counts, and might influence disease progression. Because these deleterious effects are postulated to be secondary to a direct activation of T lymphocytes induced by the immunogen, we compared immunologic and virologic effects of a T cell-dependent and a T cell-independent vaccine. Seventeen HIV-infected children were immunized with influenza (FLU) (T cell- dependent) or pneumococcal (PNEUMO) (T cell-independent) vaccines. HIV viral load and type 1 (IL-2 and IFN-γ) and type 2 (IL-4 and IL-10) cytokine production were evaluated before and 7, 14, and 28 days after vaccination. Slopes of CD4 cell counts analyzed 6 months before and 6 months after vaccination were not significantly different. HIV viral load increased in both groups of children despite the fact that type I cytokine production and the type 1-to-type 2 ratio increased in FLU-vaccinated but not in PNEUMO- vaccinated patients. Thus, an increase in HIV viral load in the absence of T cell activation (as measured by cytokine production) was observed in PNEUMO- vaccinated children. Because polysaccharides of the bacterial cell wall stimulate TNF-α production by monocyte-macrophages and TNF-α was shown to stimulate HIV replication directly on activation of NF-κb after binding the long terminal repeat (LTR) sequences of HIV, we measured TNF-α production and observed a significant increase in both groups of vaccines. These data suggest that an increase in HIV viral load can be observed in vaccinated HIV- infected children even independent of direct antigen-induced activation of T lymphocytes, and that augmented production of TNF-α might play a role in this phenomenon.
AB - Vaccination of HIV-infected individuals increases HIV viral load, reduces CD4 cell counts, and might influence disease progression. Because these deleterious effects are postulated to be secondary to a direct activation of T lymphocytes induced by the immunogen, we compared immunologic and virologic effects of a T cell-dependent and a T cell-independent vaccine. Seventeen HIV-infected children were immunized with influenza (FLU) (T cell- dependent) or pneumococcal (PNEUMO) (T cell-independent) vaccines. HIV viral load and type 1 (IL-2 and IFN-γ) and type 2 (IL-4 and IL-10) cytokine production were evaluated before and 7, 14, and 28 days after vaccination. Slopes of CD4 cell counts analyzed 6 months before and 6 months after vaccination were not significantly different. HIV viral load increased in both groups of children despite the fact that type I cytokine production and the type 1-to-type 2 ratio increased in FLU-vaccinated but not in PNEUMO- vaccinated patients. Thus, an increase in HIV viral load in the absence of T cell activation (as measured by cytokine production) was observed in PNEUMO- vaccinated children. Because polysaccharides of the bacterial cell wall stimulate TNF-α production by monocyte-macrophages and TNF-α was shown to stimulate HIV replication directly on activation of NF-κb after binding the long terminal repeat (LTR) sequences of HIV, we measured TNF-α production and observed a significant increase in both groups of vaccines. These data suggest that an increase in HIV viral load can be observed in vaccinated HIV- infected children even independent of direct antigen-induced activation of T lymphocytes, and that augmented production of TNF-α might play a role in this phenomenon.
UR - http://www.scopus.com/inward/record.url?scp=0032503529&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032503529&partnerID=8YFLogxK
M3 - Article
C2 - 9643372
AN - SCOPUS:0032503529
VL - 14
SP - 727
EP - 734
JO - AIDS Research and Human Retroviruses
JF - AIDS Research and Human Retroviruses
SN - 0889-2229
IS - 9
ER -